IRGM promotes melanoma cell survival through autophagy and is a promising prognostic biomarker for clinical application.
Tian L, Meng H, Dong X, Li X, Shi Z, Li H, Zhang L, Yang Y, Liu R, Pei C, Li B, Xu H, Li R.
Tian L, et al. Among authors: li x, li h, li b, li r.
Mol Ther Oncolytics. 2020 Dec 19;20:187-198. doi: 10.1016/j.omto.2020.12.005. eCollection 2021 Mar 26.
Mol Ther Oncolytics. 2020.
PMID: 33665357
Free PMC article.